Ultima-AOD9604 2mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
ACTIVE INGREDIENT AOD 9604 - Anti-Obesity Peptide

For enhanced security, our products are shipped without any brand labeling.

AOD 9604 is a cutting-edge peptide derived from Growth Hormone, specifically engineered to replicate the last 15 amino acids (176-191) of the Growth Hormone sequence. This unique formulation, also known as GH Frag 176-191, is celebrated for its potent weight loss capabilities and its ability to boost fat reduction and metabolic rates.

Pituitary Gland Stimulation:

• Effectively reduces body fat
• Facilitates fat release from obese fat cells more efficiently than from lean tissues
• Mimics natural growth hormone's role in fat metabolism
• Maintains stable blood sugar levels and supports overall growth
• Stimulates lipolysis (fat breakdown)
• Inhibits lipogenesis (conversion of food into body fat)
• Promotes cartilage repair and regeneration, especially when combined with peptide BPC 157

Key Benefits of AOD 9604:

How It Works:

AOD-9604, also known as Tyr-hGH Frag 176-191, stands out for its remarkable fat-burning properties without causing overeating. Unlike traditional growth hormone treatments, it does not affect blood sugar levels or promote tissue growth. AOD-9604 activates fat degradation and oxidation through a unique mechanism that operates independently of growth hormone receptors. Research across various species, including rodents, pigs, dogs, and humans, demonstrates that AOD-9604 effectively releases fat from predominantly obese fat cells, reduces new fat accumulation, and enhances fat burning?particularly targeting stubborn abdominal fat.

While CJC-1295 is another powerful fat loss peptide that boosts overall GH levels as we age, AOD-9604 distinguishes itself by avoiding increased appetite and elevated cortisol levels, making it a superior choice for those focused on weight loss.

AOD 9604 Research Insights:

Developed in the 1990s by Professor Frank Ng at Monash University, AOD-9604 aims to harness the fat-burning advantages of human growth hormone (HGH) without the muscle-building effects. Recent studies have uncovered its regenerative properties related to growth hormone, with ongoing trials investigating its potential for treating osteoarthritis, hypercholesterolemia, and enhancing bone and cartilage repair.

Crucially, AOD 9604 has shown no adverse effects on carbohydrate metabolism in oral glucose tolerance tests, a significant advantage over HGH. No anti-AOD 9604 antibodies were detected in patients, and all studies reported no serious adverse events or withdrawal symptoms.

Conclusion:

AOD 9604 boasts an impressive safety and tolerability profile, comparable to a placebo, without the side effects commonly associated with full-length HGH treatments. With an excellent safety record, AOD 9604 has recently achieved Human GRAS status in the USA, making it a reliable option for those seeking effective weight management solutions.